Research graph
References from Secondary failure of platelet recovery after allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia: Incidence, risk factors, and clinical outcomes. Local targets link to admitted publications; unresolved targets remain external evidence.
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
10.1038/s41409-018-0204-7 · 2018 · External reference
Modern Applied Statistics with S
10.1007/978-0-387-21706-2 · 2002 · External reference
Suppression of Hematopoietic Primitive Cells in Patients with Secondary Failure of Platelet Recovery after Acute Graft-versus-Host Disease
10.1016/j.bbmt.2020.06.003 · 2020 · External reference
Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation
10.1126/scitranslmed.aay7713 · 2020 · External reference
Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party
10.1016/j.bbmt.2017.12.790 · 2018 · External reference
Evaluation of Platelet Parameters in Patients With Secondary Failure of Platelet Recovery and Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation
10.1177/10760296231157741 · 2023 · External reference
Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia
10.1007/s00277-020-04106-2 · 2020 · External reference
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation
10.1007/s00277-024-05711-1 · 2024 · External reference
Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience
10.1016/j.leukres.2024.107484 · 2024 · External reference
Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT
10.1177/10760296211068037 · 2022 · External reference
Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium
10.1002/ajh.26310 · 2021 · External reference
Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges
10.1038/s41409-020-01169-7 · 2021 · External reference
Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience
10.1007/s00277-021-04706-6 · 2022 · External reference
Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation
10.1016/j.bbmt.2016.01.018 · 2016 · External reference
Development of a nomogram to predict the risk of secondary failure of platelet recovery in patients with β-thalassemia major after hematopoietic stem cell transplantation: a retrospective study
10.1177/20406207241245190 · 2024 · External reference
Secondary failure of platelet recovery after hematopoietic stem cell transplantation
10.1053/bbmt.2001.v7.pm11302549 · 2001 · External reference
Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation
10.1016/j.bbmt.2016.06.003 · 2016 · External reference
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
10.1093/cid/ciw668 · 2017 · External reference
The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
10.3389/fimmu.2022.896034 · 2022 · External reference
